E-Survey: Current Status of Proton Beam Therapy in USA
- Authors
-
-
A. Taqaddas
Research Medical Physicist, Research Wormhole, Canada; Certified International project manager Member of APS and ASCO USA Member of ESTRO, Europe
-
- Keywords:
- Cancer, Proton Beam Therapy, Intensity modulated Proton Therapy, Single field uniform scanning, Quality Assurance, Synchrotron
- Abstract
-
The clinical use of Proton Beam Therapy (PBT) in the management of cancer is increasing worldwide. USA has high number of proton therapy centres and this number is growing with new proton therapy centres under development. This study expresses the views of Proton Therapy experts from 12 US cities based in 9 states with respect to the role of proton therapy in cancer treatment. An E-survey was conducted to assess clinical, technical, educational, and organizational resources and strategies in US -based Proton Beam Therapy facilities and to recognize patters of practice. The E-survey attempted to identify tumours which are more likely to benefit from Proton beam Therapy compared to Photon based Therapy. The role of Proton Beam Therapy in Breast, Brain and Lung cancers was also studied. The study also intended to find what improvements are needed to ensure efficient treatment planning, delivery and dosimetry. This is the first study of its kind in USA.
- References
-
Taqaddas A. Unlocking the Secrets of Proton Beam Therapy. Gamma Gazette. Autumn edition: 2020; 30-33. [online] Available at: https://issuu.com/anzsnm/docs/anzsnm_ gamma_gazette_2020_autumn_edition_final [Accessed 27/11/2021].
Paganetti H. Proton beam therapy. Bristol (GB): IOP Publishing; 2017 [online] Available at: https://iopscience.iop.org/chapter/978-0-7503-1370-4/bk978-0-7503-1370-4ch1.pdf [Accessed 10/12/2021].
Chang A, Yock T, Mahajan A, Hill-Kaiser C, Keole S, Loredo L, Cahlon O, McMullen K, Hartsell W, Indelicato D. Pediatric proton therapy: patterns of care across the United States. International Journal of Particle Therapy 2014; 1(2): 357-67. https://doi.org/10.14338/IJPT.13.00009.1
Stefanowicz S, Stützer K, Zschaeck S, Jakobi A, Troost EG. Comparison of different treatment planning approaches for intensity-modulated proton therapy with simultaneous integrated boost for pancreatic cancer. Radiation Oncology 2018; 13(1): 1-1. https://doi.org/10.1186/s13014-018-1165-0
Florijn M, Sharfo A, Wiggenraad R, van Santvoort J, Petoukhova A, Hoogeman M, Mast M, Dirkx M. Lower doses to hippocampi and other brain structures for skull-base meningiomas with intensity modulated proton therapy compared to photon therapy. Radiotherapy and Oncology 2020; 142: 147-53. https://doi.org/10.1016/j.radonc.2019.08.019
Adeberg S, Harrabi S, Bougatf N, Verma V, Windisch P, Bernhardt D, Combs S, Herfarth K, Debus J, Rieken S. Dosimetric comparison of proton radiation therapy, volumetric modulated arc therapy, and three-dimensional conformal radiotherapy based on intracranial tumor location. Cancers 2018; 10(11): 401. https://doi.org/10.3390/cancers10110401
Dagan R, Bryant C, Bradley J, Indelicato D, Rutenberg M, Rotondo R, Morris C, Mendenhall W. A prospective evaluation of acute toxicity from proton therapy for targets of the parotid region. International Journal of Particle Therapy 2016; 3(2): 285-90. https://doi.org/10.14338/IJPT-16-00010.2
Holliday E, Garden A, Rosenthal D, Fuller C, Morrison W, Gunn G, Phan J, Beadle B, Zhu X, Zhang X, Hanna E. Proton therapy reduces treatment-related toxicities for patients with nasopharyngeal cancer: a case-match control study of intensity-modulated proton therapy and intensity-modulated photon therapy. International Journal of Particle Therapy 2015; 2(1): 19-28. https://doi.org/10.14338/IJPT-15-00011.1
Musielak M, Suchorska WM, Fundowicz M, Milecki P, Malicki J. Future Perspectives of Proton Therapy in Minimizing the Toxicity of Breast Cancer Radiotherapy. Journal of Personalized Medicine 2021; 11(5): 410. https://doi.org/10.3390/jpm11050410
Mast M, Vredeveld E, Credoe H, van Egmond J, Heijenbrok M, Hug E, Kalk P, van Kempen-Harteveld L, Korevaar E, van der Laan H, Langendijk J. Whole breast proton irradiation for maximal reduction of heart dose in breast cancer patients. Breast Cancer Research and Treatment 2014; 148(1): 33-9. https://doi.org/10.1007/s10549-014-3149-6
Ares C, Khan S, MacArtain A, Heuberger J, Goitein G, Gruber G, Lutters G, Hug E, Bodis S, Lomax A. Postoperative proton radiotherapy for localized and locoregional breast cancer: potential for clinically relevant improvements? International Journal of Radiation Oncology Biology Physics 2010; 76(3): 685-97. https://doi.org/10.1016/j.ijrobp.2009.02.062
Han Y. Current status of proton therapy techniques for lung cancer. Radiation Oncology Journal 2019; 37(4): 232. https://doi.org/10.3857/roj.2019.00633
RaySearch Laboratories. RayStation Comprehensive Cancer Treatment Planning [online]. 2021. Available at: https://www.raysearchlabs.com/raystation/ [Accessed 10/12/2021]
Hrbacek J, Mishra K, Kacperek A, Dendale R, Nauraye C, Auger M, Herault J, Daftari IK, Trofimov A, Shih H, Chen Y. Practice patterns analysis of ocular proton therapy centers: the international OPTIC survey. International Journal of Radiation Oncology Biology Physics 2016; 95(1): 336-43. https://doi.org/10.1016/j.ijrobp.2016.01.040
Schulte R. Strategies for image-guided proton therapy of cancer. US Oncological Disease 2007; 1(1): 75-7. https://doi.org/10.17925/OHR.2007.00.01.75
Brousmiche S, Seabra J, Labarbe R, Vila Oliva M, Rit S, et al. Design of cone-beam CT for proton therapy gantry. ESTRO 33, 2014, Vienne, Austria. pp. PO-0783. https://doi.org/10.1016/S0167-8140(15)30901-4
Zhang M, Zou W, Teo B. Image guidance in proton therapy for lung cancer. Translational Lung Cancer Research 2018; 7(2): 160. https://doi.org/10.21037/tlcr.2018.03.26
Ding X, Zheng Y, Zeidan O, Mascia A, Hsi W, Kang Y, Ramirez E, Schreuder N, Harris B. A novel daily QA system for proton therapy. Journal of Applied Clinical Medical Physics 2013; 14(2): 115-26. https://doi.org/10.1120/jacmp.v14i2.4058
Actis O, Meer D, König S, Weber D, Mayor A. A comprehensive and efficient daily quality assurance for PBS proton therapy. Physics in Medicine & Biology 2017; 62(5): 1661. https://doi.org/10.1088/1361-6560/aa5131
Arjomandy B, Taylor P, Ainsley C, Safai S, Sahoo N, Pankuch M, Farr J, Yong Park S, Klein E, Flanz J, Yorke E. AAPM task group 224: Comprehensive proton therapy machine quality assurance. Medical Physics 2019; 46(8): e678-705. https://doi.org/10.1002/mp.13622
The National association for Proton Therapy. Proton therapy centers in U.S. 2021 [online] Available at: https://www.proton-therapy.org/map/ [Accessed 27/12/2021].
Joint Technical Committee OB/7. AS NZS 4360: 1999 Risk Management. Strathfield NSW. Standards Association of Australia; 1999 [online] Available at: http://www.epsonet.eu/ mediapool/72/723588/data/2017/AS_NZS_4360-1999_Risk_management.pdf [Accessed 10/12/2021].
Risk Management Plan for Research on the Alfred Campus. Australia. Alfred Campus; 2004. [online] Available at: https://www.alfredhealth.org.au/images/resources/research/Risk-management-plan.pdf [Accessed 10/12/2021]
A guide to the Project Management Body of Knowledge (PMBOK Guide®). 2000 ed. Pennsylvania (USA): Project Management Institute, Inc; 2000. Chapter 11, Project Risk Management; p.127-146.
- Downloads
- Published
- 2021-12-07
- Issue
- Vol. 10 (2021)
- Section
- Articles
How to Cite
Similar Articles
- A. Piersigilli, A. D. Borowsky, Q. Chen, N.E. Hubbard , R.D. Cardiff , Current Concepts and New Insights from Mouse Models of Mammary Tumors on Epithelial Mesenchymal Transition and its Synergy with Mutant p53 , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Cuihong Song, Jie Liao, Zihui Deng, Jinying Zhang, Hui Xue, Yongming Li, Chen Liang, Ming Han, Jianhua Li, Guangtao Yan, Correlations between Carcinoembryonic Antigen, Epidermal Growth Factor and Leptin in Patients with Non-Small-Cell Lung Cancer , Journal of Analytical Oncology: Vol. 3 No. 1 (2014)
- Jamal Zekri, Syed Mustafa Karim, Ahmed Al-Shehri, Mervat Mahrous, Tarek Darwish, Hani El Taani, Frequency and Clinical Impact of KRAS Mutations in Patients with Colorectal Cancer from the Middle East , Journal of Analytical Oncology: Vol. 5 No. 2 (2016)
- Yervand S. Harutyunyan, Haykaz Y. Antonyan, Tigran Y. Antonyan, Lernik Y. Hambardzumyan, Sargis S. Gevorgyan, The Management of Lower Urinary Tract Obstruction in Patients with Advanced Prostate Cancer , Journal of Analytical Oncology: Vol. 4 No. 3 (2015)
- Dimitra Thomaidou , Evangelia Patsavoudi , Extracellular HSP90 in Cancer Invasion and Metastasis: From Translational Research to Clinical Prospects , Journal of Analytical Oncology: Vol. 4 No. 4 (2015)
- Zahra Jabbarpour, Mohammad H. Ghahremani, Massoud Saidijam, Jafar Kiani, Naser Ahmadbeigi, Trends of Stem Cell-Based Clinical Trials in Gastrointestinal Tract Diseases , Journal of Analytical Oncology: Vol. 9 (2020)
- Jamie Ritchey, Wilfried Karmaus, Tara Sabo-Attwood, Susan E. Steck, Hongmei Zhang, A Review of the Expression of Genes Involved in Sex Steroid Hormone Metabolism in Prostate Tissue: A Need for Epigenetic Information , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- Abdelkrim Berroukche, Ely Mohamed-Amine, Mohamed Terras, Miloud Slimani, Comparative Epidemiological Profiles in Prostate Cancer Algerian and Mauritanian Patients: Retrospective Study of 124 Case , Journal of Analytical Oncology: Vol. 7 No. 1 (2018)
- Anju Khairwa, Pooja Sharma, Sonal Sharma, Concordance and Discordance of Endometrial Biopsy vs Hysterectomy Specimen Findings for the Diagnosis of Endometrial Cancer , Journal of Analytical Oncology: Vol. 14 (2025)
- Alberto Muñoz, Eider Azkona, Estíbaliz Iza, Eluska Iruarrizaga, Abigail Ruiz de Lobera, Itziar Rubio, Joan Manel Mañé, Sergio Carrera, Inés Marrodán Ciordia , Guillermo López-Vivanco , Efficacy and Safety of Fixed-Dose-Rate Infusions of Gemcitabine Plus Erlotinib for Advanced Pancreatic Cancer , Journal of Analytical Oncology: Vol. 4 No. 1 (2015)
You may also start an advanced similarity search for this article.